A study of therapeutic effects and neuroimaging for somatoform pain disorder.

A study of therapeutic effects and neuroimaging for somatoform pain disorder. - A study of therapeutic effects and neuroimaging for somatoform pain disorder.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010344

Enrollment

Registered

2013-03-30

Start date

2010-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Somatoform pain disorder

Interventions

A psychotherapy during 3 months.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. The patients treated in Hiroshima University Hospital. 2. 20 years and up. 3. The patients diagnosed as being pain disorder by DSM-IV. 4. Accepted informed consent.

Exclusion criteria

Exclusion criteria: 1. Difficulty to understand the purpose of study (e.g. dementia, delirium, psychosis). 2. Severe physical disease. 3. Brain organic disorder (e.g. cerebral hemorrhage, brain infarction). 4. The patients prescribed opioid as a treatment.

Design outcomes

Primary

Measure	Time frame
The changes of pain intensity after a therapy	—

Secondary

Measure	Time frame
The changes of depression (BDI-II), anxiety (STAI), pain catastrophizing (PCS), QOL (SF-36) and intensity of emotion after a therapy	—

Countries

Japan

Contacts

Public ContactAtsuo Yoshino

Hiroshima University Department of Psychiatry and Neuroscience

yoshino@hiroshima-u.ac.jp082-257-5207

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026